According to the government, the UK has now secured seven million doses of the Moderna vaccine, which should be enough to administer the vaccine to around 3.5 million people. The government says that if the vaccine is approved by the Medicines and Healthcare products Regulatory Agency (MHRA), it could be delivered to the UK as early as spring 2021 – the same timetable as other countries in Europe.
Health and Social Care Secretary Matt Hancock said: “Every week, we are getting more positive news about the range of vaccines in development and thanks to the work of our taskforce the UK has pre-ordered hundreds of millions of doses from those companies most advanced in their work. This includes buying a further two million doses of Moderna’s vaccine, on top of the five million we have already secured. With a wide range of vaccine candidates in our portfolio, we stand ready to deploy a vaccine should they receive approval from our medicines regulator, starting with those who will benefit most.”
The UK government also broke down how many vaccines it has pre-ordered from various sources:
- 100 million doses of University of Oxford/AstraZeneca vaccine – Phase III clinical trials
- 40 million doses of BioNTech/Pfizer vaccine – Phase III clinical trials
- 7 million doses of Moderna vaccine – Phase III clinical trials
- 60 million doses of Novavax vaccine – Phase III clinical trials
- 60 million doses of Valneva vaccine – Pre-clinical trials
- 60 million doses of GlaxoSmithKline (GSK)/Sanofi Pasteur vaccine – Phase I clinical trials
- 30 million doses of Janssen vaccine – Phase II clinical trials.
The post UK secures total of 357 million doses of various COVID-19 vaccines appeared first on European Pharmaceutical Review.